SePP
SePP is a blood-brain barrier-permeable NMDAR antagonist and dopamine/norepinephrine reuptake inhibitor, with a Ki of 28.7 nM for rat NMDAR. SePP exerts anticonvulsant effects. SePP can be used in research related to fragile X syndrome.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C17H21NSe
- Peso molecular:318.32
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas iGluR
MoreVer todos los productos específicos de isoformas Dopamine Receptor
More
Actividad biológica
|
NMDA Receptor 28.7 nM (Ki) |
SePP (multiple concentrations; 2 h) potently binds to rat forebrain NMDARs with a Ki of 28.7 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| Species | Dose | Route | Plasma Concentration |
|---|---|---|---|
| Mice[1] | 10 mg/kg | i.p. | 387.5 ng/mL |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:FVB.129P2-Pde6b+ Tyrc‑ch Fmr1tm1Cgr/J (Fmr1 knockout, 4 male and 4 female, postnatal day 23-25, audiogenic seizure induction)[1]
-
Dosage:10 mg/kg
-
Administration:i.p.; single dose
-
Result:Abolished wild running and jumping (WRJ), tonic-clonic seizure (TCS), and respiratory arrest (RA) in all treated mice, with statistically significant differences compared to vehicle controls (P < 0.0001 for WRJ and TCS, P = 0.0013 for RA).
Exhibited normal behaviors including exploring, rearing, grooming, and interacting with cage-mates during testing.
Chemical Information
-
Peso molecular 318.32
-
Fòrmula C17H21NSe
-
SMILES
C1(CC(N2CCCCC2)C3=CC=C[Se]3)=CC=CC=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)